Back to search

United Kingdom· GB-APID-22371011000001103

Nutricology Saccharomyces Boulardii 150mg capsules

A saccharomyces boulardii product containing saccharomyces boulardii, registered in United Kingdom by Imported (United States). The same ATC class is registered in 10 of our 19 countries.

ATC A07FA02

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedNutricology Saccharomyces Boulardii 1…ATCA07FA02REGISTER NO.GB-APID-2237101100000…PACKS LISTED0CHECKEDSeptember 13, 2026

Where it is registered

Saccharomyces boulardii is registered in 10 of 19 countries.

Countries holding a registration under ATC A07FA02 (saccharomyces boulardii), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 7 of them publish a price we can compare per daily dose

Saccharomyces boulardii · ATC A07FA02

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of saccharomyces boulardii costs, country by country.

Normalised to the WHO defined daily dose (1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Saccharomyces boulardii · price per daily dose (1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$4.16
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Saccharomyces boulardii
Manufacturer
Imported (United States)
Country
United Kingdom (GB)
ATC code
A07FA02
ATC class
Saccharomyces boulardii
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Saccharomyces boulardii in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All saccharomyces boulardii products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Austria · Yomogi
  • Belgium · Sacchiflora
  • Cyprus · Bioflor
  • Germany · Boulardii Pz Entsprechend Mindestens 10^10 Lebensfähige Zellen/G, Lyophilisiert, Ceritract
  • Italy · Codex, Preparazione H
  • Portugal · Prolif
  • Sweden · Precosa
  • Slovakia · Yomogi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8e7017b1-f5ea-491d-9bb2-79b9304cf166
GET /v1/drugs/8e7017b1-f5ea-491d-9bb2-79b9304cf166?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "22371011000001103",
  "desc": "Nutricology Saccharomyces Boulardii 150mg capsules (Imported (United States))",
  "form": "Oral capsule",
  "vpid": "22375111000001100",
  "source": "dmd",
  "vtm_id": null,
  "strength": null,
  "substance": null,
  "ingredient": "Saccharomyces boulardii",
  "supplier_code": "11821411000001108"
}

See everything about saccharomyces boulardii.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.